These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22118289)

  • 1. Aristolochic acid I metabolism in the isolated perfused rat kidney.
    Priestap HA; Torres MC; Rieger RA; Dickman KG; Freshwater T; Taft DR; Barbieri MA; Iden CR
    Chem Res Toxicol; 2012 Jan; 25(1):130-9. PubMed ID: 22118289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the metabolism and reductive activation of carcinogenic aristolochic acids in rats.
    Chan W; Luo HB; Zheng Y; Cheng YK; Cai Z
    Drug Metab Dispos; 2007 Jun; 35(6):866-74. PubMed ID: 17344338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase.
    Stiborová M; Frei E; Sopko B; Sopková K; Marková V; Lanková M; Kumstýrová T; Wiessler M; Schmeiser HH
    Carcinogenesis; 2003 Oct; 24(10):1695-703. PubMed ID: 12869422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the phase I and phase II metabolism of nephrotoxin aristolochic acid by liquid chromatography/tandem mass spectrometry.
    Chan W; Cui L; Xu G; Cai Z
    Rapid Commun Mass Spectrom; 2006; 20(11):1755-60. PubMed ID: 16676316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Breuer A; Bieler CA; Schmeiser HH
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):421-7. PubMed ID: 10445409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents.
    Shibutani S; Bonala RR; Rosenquist T; Rieger R; Suzuki N; Johnson F; Miller F; Grollman AP
    Int J Cancer; 2010 Sep; 127(5):1021-7. PubMed ID: 20039324
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Dedı Ková A; Bárta F; Martínek V; Kotalík K; Dušková Š; Mráz J; Arlt VM; Stiborová M; Hodek P
    Chem Res Toxicol; 2020 Nov; 33(11):2804-2818. PubMed ID: 32894017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cytochromes P450 in metabolism of carcinogenic aristolochic acid I: evidence of their contribution to aristolochic acid I detoxication and activation in rat liver.
    Stiborova M; Mares J; Levova K; Pavlickova J; Barta F; Hodek P; Frei E; Schmeiser HH
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():121-30. PubMed ID: 22167220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the metabolism of aristolochic acids I and II.
    Krumbiegel G; Hallensleben J; Mennicke WH; Rittmann N; Roth HJ
    Xenobiotica; 1987 Aug; 17(8):981-91. PubMed ID: 3673113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Hájek M; Frei E; Schmeiser HH
    Gen Physiol Biophys; 2001 Dec; 20(4):375-92. PubMed ID: 11989648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid determination of aristolochic acids I and II in herbal products and biological samples by ultra-high-pressure liquid chromatography-tandem mass spectrometry.
    Kuo CH; Lee CW; Lin SC; Tsai IL; Lee SS; Tseng YJ; Kang JJ; Peng FC; Wei-Chu L
    Talanta; 2010 Mar; 80(5):1672-80. PubMed ID: 20152395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity.
    Chang SY; Weber EJ; Sidorenko VS; Chapron A; Yeung CK; Gao C; Mao Q; Shen D; Wang J; Rosenquist TA; Dickman KG; Neumann T; Grollman AP; Kelly EJ; Himmelfarb J; Eaton DL
    JCI Insight; 2017 Nov; 2(22):. PubMed ID: 29202460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Sopko B; Wiessler M; Schmeiser HH
    Carcinogenesis; 2002 Apr; 23(4):617-25. PubMed ID: 11960915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive measurement of aristolochic acid-DNA adducts in urine samples from aristolochic acid-treated rats by liquid chromatography coupled tandem mass spectrometry: evidence for DNA repair by nucleotide-excision repair mechanisms.
    Leung EM; Chan W
    Mutat Res; 2014; 766-767():1-6. PubMed ID: 25847264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy.
    Stiborová M; Frei E; Arlt VM; Schmeiser HH
    Mutat Res; 2008; 658(1-2):55-67. PubMed ID: 17851120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.
    Stiborova M; Frei E; Arlt VM; Schmeiser HH
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):5-11. PubMed ID: 19365519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytochromes P450 1A1 and 1A2 participate in detoxication of carcinogenic aristolochic acid.
    Sistkova J; Hudecek J; Hodek P; Frei E; Schmeiser HH; Stiborova M
    Neuro Endocrinol Lett; 2008 Oct; 29(5):733-7. PubMed ID: 18987598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of aristolochic acid-derived DNA adducts in rat kidney and liver by using liquid chromatography-electrospray ionization mass spectrometry.
    Chan W; Yue H; Poon WT; Chan YW; Schmitz OJ; Kwong DW; Wong RN; Cai Z
    Mutat Res; 2008 Nov; 646(1-2):17-24. PubMed ID: 18812181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous toxicokinetic studies of aristolochic acid I and II and aristolactam I and II using a newly-developed microdialysis liquid chromatography-tandem mass spectrometry.
    Chiang SY; Wey MT; Luo YS; Shih WC; Chimeddulam D; Hsu PC; Huang HF; Tsai TH; Wu KY
    Food Chem Toxicol; 2023 Jul; 177():113856. PubMed ID: 37257633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -- (32)P-postlabeling analysis of DNA adduct formation.
    Stiborová M; Frei E; Breuer A; Wiessler M; Schmeiser HH
    Mutat Res; 2001 Jun; 493(1-2):149-60. PubMed ID: 11516724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.